2012-2014年我院门诊质子泵抑制剂应用情况分析

发布时间：2018-05-20 00:33

本文选题：质子泵抑制剂 + ABC分析法　；参考：《中国执业药师》2016年02期

【摘要】：目的:分析我院门诊质子泵抑制剂(PPIs)的使用情况,为临床合理用药和有效管理提供参考。方法:采用ABC分析法和限定日剂量(DDD)法对PPIs的种类、用量、销售金额、用药频度(DDDs)、日均费用(DDC)和序号比值等数据进行统计分析,并对A类药品和DDDs高的品种进行重点分析。结果:2012-2014年,A类药品占药品总品种数的20.0%~33.3%,B类药品占11.1%~22.2%,C类药品占44.5%~60.0%,其中A类各个药品的销售金额均呈逐年增加趋势。近3年,PPIs的总DDDs和总销售金额呈快速增长趋势,其中埃索美拉唑镁肠溶片(耐信)DDDs连续两年居首位,其销售金额连续3年居首位。大多数PPIs的序号比值接近于1.0。结论:我院PPIs临床应用结构存在不合理现象,尤其是A类药品所占比重偏大,有待加强管理。PPIs的销售金额与用药频度同步性较好,使用基本合理,但仍有改进之处。
[Abstract]:Objective: to analyze the use of proton pump inhibitor PPIsin in outpatient clinic and to provide reference for rational drug use and effective management. Methods: the ABC analysis method and the method of limited daily dose were used to analyze the data of PPIs, such as the type, dosage, sales amount, frequency of drug use, daily average cost and serial number ratio, and the emphasis was put on the analysis of A drugs and the high DDDs varieties. Results from 2012 to 2014, 20.0% of the total number of drugs in Group A accounted for 33.33.3% of the total number of drugs of Group B, and the proportion of Category B drugs accounted for 11.1% and 22.2C drugs accounted for 64.5% of the total number of drugs, and the sales amount of each drug of Category A showed a trend of increasing year by year. In the last three years, the total DDDs and the total sales amount of the PPIs showed a rapid growth trend, among which esomeprazole magnesium enteric-coated tablets (DDDs) ranked first for two consecutive years, and the sales amount was the first for the third consecutive year. Most PPIs ordinal ratios are close to 1.0. Conclusion: the clinical application structure of PPIs in our hospital is unreasonable, especially the proportion of class A drugs is on the high side.
【作者单位】：青岛大学附属医院;
【分类号】：R969.3

【相似文献】